与镓-PSMA-11正电子发射断层显像（PET）成像相比，F-PSMA-1007在鉴别局部复发与尿路示踪剂排泄方面的优势。 - Suppr

Suppr

超能文献

Advantage of F-PSMA-1007 over Ga-PSMA-11 PET imaging for differentiation of local recurrence vs. urinary tracer excretion.

作者信息

Rahbar Kambiz, Weckesser Matthias, Ahmadzadehfar Hojjat, Schäfers Michael, Stegger Lars, Bögemann Martin

机构信息

Department of Nuclear Medicine, University Hospital Muenster, 48149, Münster, Germany.

Department of Nuclear Medicine, University Hospital Bonn, Bonn, Germany.

出版信息

Eur J Nucl Med Mol Imaging. 2018 Jun;45(6):1076-1077. doi: 10.1007/s00259-018-3952-0. Epub 2018 Feb 14.

DOI:10.1007/s00259-018-3952-0

PMID:29445927

Abstract

摘要

相似文献

Advantage of F-PSMA-1007 over Ga-PSMA-11 PET imaging for differentiation of local recurrence vs. urinary tracer excretion.与镓-PSMA-11正电子发射断层显像（PET）成像相比，F-PSMA-1007在鉴别局部复发与尿路示踪剂排泄方面的优势。

Eur J Nucl Med Mol Imaging. 2018 Jun;45(6):1076-1077. doi: 10.1007/s00259-018-3952-0. Epub 2018 Feb 14.

More advantages in detecting bone and soft tissue metastases from prostate cancer using F-PSMA PET/CT.使用F-PSMA PET/CT检测前列腺癌骨和软组织转移方面有更多优势。

Hell J Nucl Med. 2019 Jan-Apr;22(1):6-9. doi: 10.1967/s002449910952. Epub 2019 Mar 7.

Early dynamic imaging in Ga- PSMA-11 PET/CT allows discrimination of urinary bladder activity and prostate cancer lesions.镓-PSMA-11正电子发射断层显像/计算机断层扫描（PET/CT）中的早期动态成像能够区分膀胱活动和前列腺癌病灶。

Eur J Nucl Med Mol Imaging. 2017 May;44(5):765-775. doi: 10.1007/s00259-016-3578-z. Epub 2016 Nov 29.

Early PET imaging with [68]Ga-PSMA-11 increases the detection rate of local recurrence in prostate cancer patients with biochemical recurrence.使用[68]Ga-PSMA-11进行早期PET成像可提高生化复发的前列腺癌患者局部复发的检出率。

Eur J Nucl Med Mol Imaging. 2017 Sep;44(10):1647-1655. doi: 10.1007/s00259-017-3743-z. Epub 2017 Jun 6.

Detection of Local Relapse of Prostate Cancer With 18F-PSMA-1007.使用 18F-PSMA-1007 检测前列腺癌局部复发。

Clin Nucl Med. 2019 Jun;44(6):e394-e395. doi: 10.1097/RLU.0000000000002543.

Local recurrence of prostate cancer after radical prostatectomy is at risk to be missed in Ga-PSMA-11-PET of PET/CT and PET/MRI: comparison with mpMRI integrated in simultaneous PET/MRI.前列腺癌根治术后的局部复发在PET/CT和PET/MRI的镓-PSMA-11-PET检查中可能被漏诊：与同时PET/MRI中整合的多参数MRI对比。

Eur J Nucl Med Mol Imaging. 2017 May;44(5):776-787. doi: 10.1007/s00259-016-3594-z. Epub 2016 Dec 17.

[18F]PSMA-1007 PET Improves the Diagnosis of Local Recurrence and Lymph Node Metastases in a Prostate Cancer Patient With a History of Bilateral Hip Arthroplasty.[18F]PSMA - 1007正电子发射断层扫描（PET）改善了对一名有双侧髋关节置换术病史的前列腺癌患者局部复发和淋巴结转移的诊断。

Clin Genitourin Cancer. 2018 Apr;16(2):111-113. doi: 10.1016/j.clgc.2017.11.008. Epub 2017 Dec 6.

(68)Ga-PSMA ligand PET versus (18)F-NaF PET: evaluation of response to (223)Ra therapy in a prostate cancer patient.（68）镓-PSMA配体PET与（18）F-NaF PET对比：对一名前列腺癌患者镭-223治疗反应的评估

Eur J Nucl Med Mol Imaging. 2015 Feb;42(2):362-3. doi: 10.1007/s00259-014-2922-4. Epub 2014 Oct 8.

Detection Efficacy of F-PSMA-1007 PET/CT in 251 Patients with Biochemical Recurrence of Prostate Cancer After Radical Prostatectomy.F-PSMA-1007 PET/CT 在 251 例前列腺癌根治术后生化复发患者中的检测效能。

J Nucl Med. 2019 Mar;60(3):362-368. doi: 10.2967/jnumed.118.212233. Epub 2018 Jul 24.

Value of 68Ga-PSMA HBED-CC PET for the Assessment of Lymph Node Metastases in Prostate Cancer Patients with Biochemical Recurrence: Comparison with Histopathology After Salvage Lymphadenectomy.68Ga-PSMA HBED-CC PET 对生化复发前列腺癌患者淋巴结转移评估的价值：与挽救性淋巴结切除术后组织病理学的比较。

J Nucl Med. 2016 Nov;57(11):1713-1719. doi: 10.2967/jnumed.116.173492. Epub 2016 Jun 3.

引用本文的文献

Furosemide Reduces Radionuclide Activity in the Bladder in F-PSMA-1007-PET/CT: A Single-Center Retrospective Intra-Individual Comparative Study.呋塞米降低F-PSMA-1007-PET/CT检查中膀胱内的放射性核素活性：一项单中心回顾性个体内比较研究。

Diagnostics (Basel). 2025 Jul 31;15(15):1931. doi: 10.3390/diagnostics15151931.

The impact of patient hydration and forced diuresis on [F]PSMA-1007 urinary bladder uptake in PET/CT imaging.患者水化和强制利尿对PET/CT成像中[F]PSMA - 1007膀胱摄取的影响。

EJNMMI Res. 2025 Jun 19;15(1):73. doi: 10.1186/s13550-025-01271-1.

(F)-PSMA-1007PET/CT in patients with biochemical recurrence after radical prostatectomy: Diagnostic performance and impact on treatment management.根治性前列腺切除术后生化复发患者的（F）-PSMA-1007 PET/CT：诊断性能及对治疗管理的影响

Res Diagn Interv Imaging. 2023 Jan 7;5:100021. doi: 10.1016/j.redii.2022.100021. eCollection 2023 Mar.

Application of 18F-PSMA-1007 PET/MR Imaging in Early Biochemical Recurrence of Prostate Cancer: Results of a Prospective Study of 60 Patients with Very Low PSA Levels ≤ 0.5 ng/mL.18F-PSMA-1007 PET/MR成像在前列腺癌早期生化复发中的应用：60例前列腺特异性抗原（PSA）水平极低（≤0.5 ng/mL）患者的前瞻性研究结果

Cancers (Basel). 2023 Aug 20;15(16):4185. doi: 10.3390/cancers15164185.

F-PSMA-1007 PET/CT-derived semi-quantitative parameters for risk stratification of newly diagnosed prostate cancer.F-PSMA-1007 PET/CT衍生的半定量参数用于新诊断前列腺癌的风险分层

Front Oncol. 2022 Dec 7;12:1025930. doi: 10.3389/fonc.2022.1025930. eCollection 2022.

PSMA PET-CT in the Diagnosis and Staging of Prostate Cancer.前列腺特异性膜抗原正电子发射断层扫描计算机断层扫描在前列腺癌诊断及分期中的应用

Diagnostics (Basel). 2022 Oct 26;12(11):2594. doi: 10.3390/diagnostics12112594.

PET Oncological Radiopharmaceuticals: Current Status and Perspectives.正电子肿瘤放射药物学：现状与展望。

Molecules. 2022 Oct 11;27(20):6790. doi: 10.3390/molecules27206790.

Primary Staging of Prostate Cancer Patients with [F]PSMA-1007 PET/CT Compared with [Ga]Ga-PSMA-11 PET/CT.[F]PSMA - 1007 PET/CT与[Ga]Ga - PSMA - 11 PET/CT对前列腺癌患者的初始分期比较。

J Clin Med. 2022 Aug 29;11(17):5064. doi: 10.3390/jcm11175064.

The Role of PSMA PET/CT in the Primary Diagnosis and Follow-Up of Prostate Cancer-A Practical Clinical Review.PSMA PET/CT在前列腺癌初诊及随访中的作用——一项实用临床综述

Cancers (Basel). 2022 Jul 26;14(15):3638. doi: 10.3390/cancers14153638.

Gross tumor volume delineation in primary prostate cancer on F-PSMA-1007 PET/MRI and Ga-PSMA-11 PET/MRI.在 F-PSMA-1007 PET/MRI 和 Ga-PSMA-11 PET/MRI 上对原发性前列腺癌进行大体肿瘤体积勾画。

Cancer Imaging. 2022 Jul 22;22(1):36. doi: 10.1186/s40644-022-00475-1.

本文引用的文献

Diagnostic performance of Ga-PSMA-11 (HBED-CC) PET/CT in patients with recurrent prostate cancer: evaluation in 1007 patients.镓-PSMA-11（HBED-CC）PET/CT对复发性前列腺癌患者的诊断效能：1007例患者的评估

Eur J Nucl Med Mol Imaging. 2017 Aug;44(8):1258-1268. doi: 10.1007/s00259-017-3711-7. Epub 2017 May 12.

F-18 labelled PSMA-1007: biodistribution, radiation dosimetry and histopathological validation of tumor lesions in prostate cancer patients.F-18标记的PSMA-1007：前列腺癌患者肿瘤病灶的生物分布、辐射剂量测定及组织病理学验证

Eur J Nucl Med Mol Imaging. 2017 Apr;44(4):678-688. doi: 10.1007/s00259-016-3573-4. Epub 2016 Nov 26.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验